Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

June 8, 2026

More like this

Hybridopa Shows Motor, Nonmotor Gains in Phase 2a Parkinson Disease Trial

Neurology Live

Remepy’s app-drug combo heads for Phase III on mid-stage Parkinson’s win

Clinical Trials Arena

Remepy's hybrid Parkinson's therapy poised for phase 3

Pharmaphorum